-
From February 1, 2019 to October 31, 2021, 1,047 ESS-treated CRS patients were enrolled in this study (Table 1, Figure 1). The median age of patients at surgery in this cohort was 36 (IQR 27–46) years. Of the patients, 600 (57.3%) patients were male, 764 (73.0%) patients had CRSwNP, 315 (30.1%) patients belonged to low-income status, and 362 (34.6%) patients were farmers, temporary workers, or unemployed, and 172 (16.4%) patients had no medical insurance and paid at their own expense. Compared with patients in the middle SES group, those in the low or high SES groups were older at the time of surgery (P < 0.001) and had higher preoperative FnNO levels (P = 0.039). In addition, the proportion of patients with medical insurance in the high SES group was higher than that in the low and middle SES groups (P < 0.001).
Table 1. Baseline characteristics and clinical features of patients with severe chronic rhinosinusitis (CRS) (n = 1,047) by socioeconomic status tertiles
Characteristics Total (n = 1,047) Low (n = 310) Middle (n = 399) High (n = 338) P-value Age at operation years 34.2 (27.5−46.1) 36.8 (31.8−50.8) 30.6 (24.3−48.9) 36.6 (30.6−44.1) < 0.001 Sex, n (%) 0.626 Males 600 (57.3) 183 (59.0) 230 (57.6) 187 (55.3) Females 447 (42.7) 127 (41.0) 169 (42.4) 151 (44.7) BMI, kg/m2 22.6 (20.6−27.2) 22.8 (20.7−27.3) 22.5 (20.6−27.6) 22.0 (20.4−26.7) 0.594 Educationa, n (%) < High school 92 (8.8) 83 (27.0) 9 (2.2) 0 (0.0) < 0.001 High school 273 (26.2) 178 (58.0) 92 (23.1) 3 (0.9) ≥ College 676 (65.0) 46 (15.0) 298 (74.7) 332 (99.1) Occupation, n (%) < 0.001 Low 362 (34.6) 169 (54.5) 187 (46.9) 6 (1.8) Medium 313 (29.9) 138 (44.5) 89 (22.3) 86 (25.4) High 372 (35.5) 3 (1.0) 123 (30.8) 246 (72.8) Household income/montha, n (%) < 0.001 < ¥5,000 315 (30.2) 124 (40.0) 151 (37.8) 40 (11.9) ¥5,000–8,000 638 (61.1) 186 (60.0) 243 (60.9) 209 (62.4) > ¥8,000 91 (8.7) 0 (0.0) 5 (1.3) 86 (25.7) Nasal polyposis, n (%) 0.607 Without 283 (27.0) 80 (25.8) 105 (26.3) 98 (29.0) With 764 (73.0) 230 (74.2) 294 (73.7) 240 (71.0) Smoking, n (%) 0.538 No 683 (65.2) 203 (65.5) 267 (66.9) 213 (63.0) Yes 364 (34.8) 107 (34.5) 132 (33.1) 125 (37.0) Alcohol, n (%) 0.302 No 697 (66.6) 212 (68.4) 271 (67.9) 214 (63.3) Yes 350 (33.4) 98 (31.6) 128 (32.1) 124 (36.7) Dietary patternsa, n (%) 0.466 Vegetarian-based 134 (13.3) 36 (13.2) 56 (14.0) 42 (12.4) Meat-based 67 (6.6) 24 (8.8) 25 (6.3) 18 (5.3) Mixed 809 (80.1) 213 (78.0) 318 (79.7) 278 (82.2) Furry/feathery Pets, n (%) 0.356 No 892 (85.2) 271 (87.4) 339 (85.0) 282 (83.4) Yes 155 (14.8) 39 (12.6) 60 (15.0) 56 (16.6) New furniture/redecoration, n (%) 0.593 No 902 (86.2) 267 (86.1) 339 (85.0) 296 (87.6) Yes 145 (86.1) 43 (13.9) 60 (15.0) 42 (12.4) Stressful work or family events during the first 1 yearab, n (%) 0.235 No 711 (68.1) 207 (66.8) 284 (71.2) 220 (65.7) Yes 333 (31.9) 103 (33.2) 115 (28.8) 115 (34.3) Often stay up late, n (%) 0.296 No 788 (75.3) 243 (78.4) 293 (73.4) 252 (74.6) Yes 259 (24.7) 67 (21.6) 106 (26.6) 86 (25.4) Before surgery, n (%) FeNO, ppb 24.0 (16.0−34.0) 22.0 (15.0−36.0) 24.0 (18.0−33.0) 26.0 (19.0−33.0) 0.293 FnNO, ppb 201.0 (151.0−322.0) 220.0 (168.0−335.0) 187.0 (145.0−311.0) 213.0 (169.0−323.0) 0.039 Hb, g/L 146.0 (136.0−161.0) 146.5 (140.0−166.0) 142.0 (121.0−162.0) 146.0 (136.0−157.0) 0.711 IgE, IU/mL 44.4 (30.8−66.0) 42.3 (30.3−77.4) 46.0 (31.1−56.0) 47.6 (34.9−60.8) 0.284 Medical insurance, n (%) < 0.001 No 172 (16.4) 83 (26.8) 86 (21.6) 3 (0.9) Yes 875 (83.6) 227 (73.2) 313 (78.4) 335 (99.1) Note. aTotal numbers were not equal to 1,047 for these characteristics due to missing data. bAmong work, separation/divorce, loss of job, serious health problem, or death of a family member or close relative. Values are n (%) or median (IQR). -
Kaplan-Meier analysis (Figure 2, Supplementary Table S1, available in www.besjournal.com) showed that the recovery rates of 1,047 CRS patients at 12 weeks and 24 weeks after operation were 19.1% (95% CI: 18.3%–19.9%) and 44.7% (95% CI: 43.7%–45.7%), respectively.
The log-rank tests showed that after follow-up at 24 weeks, the recovery rate (90.4%, 95% CI: 89.6%–91.2%) of patients of middle SES was higher than those of patients of low SES (13.5%, 95% CI: 12.8%–14.2%) and high SES (31.7%, 95% CI: 30.7%–32.7%) (log-rank P < 0.001). In addition, multivariate Cox regression model analysis showed that SES had no association with nasal polyps (Pinteraction = 0.189), medical insurance mode (Pinteraction = 0.143), and dietary pattern (Pinteraction = 0.438) (Supplementary Table S2, available in www.besjournal.com).
Table S2. Multivariable Cox regression model of an interaction between socioeconomic status (SES) and nasal polyposis, medical insurance, and dietary patterns
Interaction β Wald HR (95% CI) P−Value SES × nasal polyps 0.001 1.722 1.001 (0.999−1.003) 0.189 SES × medical insurance −0.056 2.144 0.946 (0.877−1.019) 0.143 SES × dietary patterns 0.092 0.601 1.097 (0.868−1.385) 0.438 Note. HR, hazard ratio; NA, not applicable. Based on the literature, we selected variables (surgical age, BMI, nasal polyps, smoking, dietary pattern, stress events, FeNO, FnNO, Hb, and medical insurance mode) that might affect prognosis and carried out univariate Cox regression model analysis, followed by multivariate Cox regression model analysis to determine their association with SES. Next, we obtained the influence of SES after adjusting the covariates for recovery rate (Figure 3, Table 2).
Figure 3. Adjusted survival curves for all-cause recurrence by socioeconomic status. Models were adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful family events during the year that precede the operation, FeNO, FnNO, Hb, and medical insurance. FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; and Hb, hemoglobin.
Table 2. Univariable and multivariable Cox regression model of factors associated with all-cause recurrence
Characteristics All-cause non-recovery Crude HR (95% CI) P-value Adjusted HR* (95% CI) P-value Socioeconomic status Low 10.42 (8.55−12.66) < 0.001 7.69 (6.17−9.71) < 0.001 High 6.54 (5.49−7.81) < 0.001 6.19 (4.78−7.93) < 0.001 Middle 1 (ref) 1 (ref) Age at operation, years 1.01 (1.00−1.02) 0.013 1.01 (0.99−1.02) 0.128 Sex Males 0.86 (0.72−1.01) 0.27 0.93 (0.79−1.08) 0.313 Females 1 (ref) 1 (ref) BMI, kg/m2 1.02 (1.00−1.03) 0.19 NA Nasal polyposis Without 0.75 (0.65−0.87) < 0.001 0.83 (0.69−1.00) 0.039 With 1 (ref) 1 (ref) Smoking NA No 0.87 (0.76−0.99) 0.039 Yes 1 (ref) Alcohol NA No 1.03 (0.89−1.19) 0.648 Yes 1 (ref) Dietary patterns* Vegetarian-based 2.11 (1.69−2.64) < 0.001 1.45 (0.87−2.42) 0.149 Meat-based 1.66 (1.23−2.22) 0.001 0.88 (0.50−1.52) 0.631 Mixed 1 (ref) 1 (ref) Furry/feathery Pets NA No 0.94 (0.78−1.13) 0.511 Yes 1 (ref) New furniture/redecoration NA No 0.89 (0.73−1.08) 0.231 Yes 1 (ref) Stressful work or family events
during the first 1 yearNo 0.80 (0.66−0.99) 0.032 1.02 (0.80−1.30) 0.871 Yes 1 (ref) 1 (ref) Often stay up late No 1.00 (0.85−1.17) 0.989 NA Yes 1 (ref) Before surgery FeNO, ppb 1.00 (1.00−1.01) < 0.001 1.00 (0.98−1.02) 0.954 FnNO, ppb 0.99 (0.99−1.00) 0.001 0.99 (0.99−1.01) 0.196 Hb, g/L 1.00 (1.00−1.01) 0.025 0.99 (0.98−1.01) 0.122 IgE, IU/mL 1.00 (0.99−1.01) 0.538 1.00 (1.00−1.01) 0.032 Medical insurance No 1.26 (1.19−1.33) < 0.001 1.23 (1.07−1.42) 0.003 Yes 1 (ref) 1 (ref) Note. CRS, chronic sinusitis; FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; HR, hazard ratio; NA, not applicable. *Adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful work or family events during the first 1 year, FeNO, FnNO, Hb, and medical insurance. SES was an independent predictor of postoperative all-cause non-recovery in CRS patients after adjusting for other covariates. During the whole follow-up period of 72 weeks, the risk of non-recovery of patients of low and high SES was significantly higher than that of patients of middle SES.
Patients of low SES had the highest risk of non-recovery, with an HR of 7.69 (95% CI: 6.17–9.71, Ptrend < 0.001), followed by patients of high SES, with HR of 6.19 (95 % CI: 4.78–7.93, Ptrend < 0.001) (Figure 3, Table 2).
-
In sensitivity analysis, we assumed that all the 44 patients lost to follow-up had reached the end point of recovery. Therefore, we performed univariate and multivariate Cox regression analyses, which yielded similar outcomes: HRs for recurrence were 8.77 (95% CI: 7.09–10.87) for the low SES group and 7.19 (95% CI: 5.95–8.70) for the high SES group, compared with the middle SES group (Ptrend < 0.001) (Supplementary Table S3, available in www.besjournal.com).
Table S3. Univariable and multivariable Cox regression model of factors associated with all-cause recurrence (All chronic sinusitis patients lost to follow-up are regarded as recovery)
Characteristics All-cause non-recovery Adjusted HR* (95% CI) P-value Socioeconomic status Low 8.77 (7.09−10.87) < 0.001 High 7.19 (5.95−8.70) < 0.001 Middle 1 (ref) Age at operation, years 0.99 (0.98−1.00) 0.111 Sex Males 0.97 (0.83−1.13) 0.722 Females 1 (ref) Nasal polyposis Without 0.88 (0.74−1.05) 0.026 With 1 (ref) Dietary patterns Vegetarian-based 1.52 (0.98−2.51) 0.747 Meat-based 0.64 (0.54−1.54) 0.058 Mixed 1 (ref) Stressful work or family events during the first 1 year No 0.99 (0.80−1.23) 0.919 Yes 1 (ref) Before surgery FeNO, ppb 1.00 (1.00−1.00) 0.527 FnNO, ppb 1.00 (1.00−1.00) 0.224 Hb, g/L 1.00 (1.00−1.01) 0.113 IgE, IU/mL 1.00 (1.00−1.00) 0.538 Medical insurance No 1.23 (1.06−1.56) 0.023 Yes 1 (ref) Note. CRS, chronic sinusitis; FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; HR, hazard ratio; NA, not applicable. *Adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful work or family events during the first 1 year, FeNO, FnNO, Hb, and medical insurance. -
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
-
Table S1. Kaplan-Meier analysis of the recovery rate (%) (95 % confidence interval) and Log-rank tests after 24 weeks follow-up
Time (week) Total (n = 1,047) Low (n = 310) Middle (n = 399) High (n = 338) 12 19.1 (18.3−19.9) 3.2 (2.1−4.9) 30.9 (29.2−31.8) 4.7 (3.1−5.9) 24 44.7 (43.7−45.7) 13.5 (12.8−14.2) 90.4 (89.6−91.2) 31.7 (30.7−32.7)
doi: 10.3967/bes2023.135
Socioeconomic Status Impacts the Prognosis of Chronic Rhinosinusitis Treated by Endoscopic Sinus Surgery: An Observational Cohort Study in Northeast China
-
Abstract:
Objective To explore the association between socioeconomic status (SES) and postoperative outcomes in patients with chronic sinusitis (CRS) after functional endoscopic sinus surgery (ESS). Methods We conducted an observational cohort study of 1,047 patients with CRS undergoing ESS. Discharged patients were followed up to 72 weeks for all-cause recurrence events. Baseline SES was established based on occupation, education level, and family income of the patients 1 year before the operation. Kaplan–Meier method was used to calculate the recovery rate after ESS, and Cox proportional hazards regression analysis was used to evaluate the relationship between SES and prognosis. Results Patients of middle SES had lower unadjusted all-cause recurrence than those of low or high SES; 24-week overall recovery rate was 90.4% [95 % confidence interval (CI): 89.6%–91.2%] in patients of middle SES, 13.5% (95 % CI: 12.8%–14.2%) in patients of low SES, and 31.7% (95 % CI: 30.7%–32.7%) in patients of high SES (both log-rank P < 0.001). After adjustment for covariates, hazard ratios (HRs) were 7.69 (95 % CI: 6.17–9.71, Ptrend < 0.001) for all-cause recurrence for low SES versus middle SES, and 6.19 (95 % CI: 4.78–7.93, Ptrend < 0.001) for middle SES versus high SES. Conclusion Low SES and high SES were more associated with the worse prognosis of CRS patients after ESS than middle SES. -
Key words:
- Chronic rhinosinusitis /
- Endoscopic sinus surgery /
- Socioeconomic status
The authors declare no conflict of interest.
注释:1) AUTHORS’ CONTRIBUTIONS: 2) CONFLICTS OF INTEREST: -
Figure 3. Adjusted survival curves for all-cause recurrence by socioeconomic status. Models were adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful family events during the year that precede the operation, FeNO, FnNO, Hb, and medical insurance. FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; and Hb, hemoglobin.
Table 1. Baseline characteristics and clinical features of patients with severe chronic rhinosinusitis (CRS) (n = 1,047) by socioeconomic status tertiles
Characteristics Total (n = 1,047) Low (n = 310) Middle (n = 399) High (n = 338) P-value Age at operation years 34.2 (27.5−46.1) 36.8 (31.8−50.8) 30.6 (24.3−48.9) 36.6 (30.6−44.1) < 0.001 Sex, n (%) 0.626 Males 600 (57.3) 183 (59.0) 230 (57.6) 187 (55.3) Females 447 (42.7) 127 (41.0) 169 (42.4) 151 (44.7) BMI, kg/m2 22.6 (20.6−27.2) 22.8 (20.7−27.3) 22.5 (20.6−27.6) 22.0 (20.4−26.7) 0.594 Educationa, n (%) < High school 92 (8.8) 83 (27.0) 9 (2.2) 0 (0.0) < 0.001 High school 273 (26.2) 178 (58.0) 92 (23.1) 3 (0.9) ≥ College 676 (65.0) 46 (15.0) 298 (74.7) 332 (99.1) Occupation, n (%) < 0.001 Low 362 (34.6) 169 (54.5) 187 (46.9) 6 (1.8) Medium 313 (29.9) 138 (44.5) 89 (22.3) 86 (25.4) High 372 (35.5) 3 (1.0) 123 (30.8) 246 (72.8) Household income/montha, n (%) < 0.001 < ¥5,000 315 (30.2) 124 (40.0) 151 (37.8) 40 (11.9) ¥5,000–8,000 638 (61.1) 186 (60.0) 243 (60.9) 209 (62.4) > ¥8,000 91 (8.7) 0 (0.0) 5 (1.3) 86 (25.7) Nasal polyposis, n (%) 0.607 Without 283 (27.0) 80 (25.8) 105 (26.3) 98 (29.0) With 764 (73.0) 230 (74.2) 294 (73.7) 240 (71.0) Smoking, n (%) 0.538 No 683 (65.2) 203 (65.5) 267 (66.9) 213 (63.0) Yes 364 (34.8) 107 (34.5) 132 (33.1) 125 (37.0) Alcohol, n (%) 0.302 No 697 (66.6) 212 (68.4) 271 (67.9) 214 (63.3) Yes 350 (33.4) 98 (31.6) 128 (32.1) 124 (36.7) Dietary patternsa, n (%) 0.466 Vegetarian-based 134 (13.3) 36 (13.2) 56 (14.0) 42 (12.4) Meat-based 67 (6.6) 24 (8.8) 25 (6.3) 18 (5.3) Mixed 809 (80.1) 213 (78.0) 318 (79.7) 278 (82.2) Furry/feathery Pets, n (%) 0.356 No 892 (85.2) 271 (87.4) 339 (85.0) 282 (83.4) Yes 155 (14.8) 39 (12.6) 60 (15.0) 56 (16.6) New furniture/redecoration, n (%) 0.593 No 902 (86.2) 267 (86.1) 339 (85.0) 296 (87.6) Yes 145 (86.1) 43 (13.9) 60 (15.0) 42 (12.4) Stressful work or family events during the first 1 yearab, n (%) 0.235 No 711 (68.1) 207 (66.8) 284 (71.2) 220 (65.7) Yes 333 (31.9) 103 (33.2) 115 (28.8) 115 (34.3) Often stay up late, n (%) 0.296 No 788 (75.3) 243 (78.4) 293 (73.4) 252 (74.6) Yes 259 (24.7) 67 (21.6) 106 (26.6) 86 (25.4) Before surgery, n (%) FeNO, ppb 24.0 (16.0−34.0) 22.0 (15.0−36.0) 24.0 (18.0−33.0) 26.0 (19.0−33.0) 0.293 FnNO, ppb 201.0 (151.0−322.0) 220.0 (168.0−335.0) 187.0 (145.0−311.0) 213.0 (169.0−323.0) 0.039 Hb, g/L 146.0 (136.0−161.0) 146.5 (140.0−166.0) 142.0 (121.0−162.0) 146.0 (136.0−157.0) 0.711 IgE, IU/mL 44.4 (30.8−66.0) 42.3 (30.3−77.4) 46.0 (31.1−56.0) 47.6 (34.9−60.8) 0.284 Medical insurance, n (%) < 0.001 No 172 (16.4) 83 (26.8) 86 (21.6) 3 (0.9) Yes 875 (83.6) 227 (73.2) 313 (78.4) 335 (99.1) Note. aTotal numbers were not equal to 1,047 for these characteristics due to missing data. bAmong work, separation/divorce, loss of job, serious health problem, or death of a family member or close relative. Values are n (%) or median (IQR). S2. Multivariable Cox regression model of an interaction between socioeconomic status (SES) and nasal polyposis, medical insurance, and dietary patterns
Interaction β Wald HR (95% CI) P−Value SES × nasal polyps 0.001 1.722 1.001 (0.999−1.003) 0.189 SES × medical insurance −0.056 2.144 0.946 (0.877−1.019) 0.143 SES × dietary patterns 0.092 0.601 1.097 (0.868−1.385) 0.438 Note. HR, hazard ratio; NA, not applicable. Table 2. Univariable and multivariable Cox regression model of factors associated with all-cause recurrence
Characteristics All-cause non-recovery Crude HR (95% CI) P-value Adjusted HR* (95% CI) P-value Socioeconomic status Low 10.42 (8.55−12.66) < 0.001 7.69 (6.17−9.71) < 0.001 High 6.54 (5.49−7.81) < 0.001 6.19 (4.78−7.93) < 0.001 Middle 1 (ref) 1 (ref) Age at operation, years 1.01 (1.00−1.02) 0.013 1.01 (0.99−1.02) 0.128 Sex Males 0.86 (0.72−1.01) 0.27 0.93 (0.79−1.08) 0.313 Females 1 (ref) 1 (ref) BMI, kg/m2 1.02 (1.00−1.03) 0.19 NA Nasal polyposis Without 0.75 (0.65−0.87) < 0.001 0.83 (0.69−1.00) 0.039 With 1 (ref) 1 (ref) Smoking NA No 0.87 (0.76−0.99) 0.039 Yes 1 (ref) Alcohol NA No 1.03 (0.89−1.19) 0.648 Yes 1 (ref) Dietary patterns* Vegetarian-based 2.11 (1.69−2.64) < 0.001 1.45 (0.87−2.42) 0.149 Meat-based 1.66 (1.23−2.22) 0.001 0.88 (0.50−1.52) 0.631 Mixed 1 (ref) 1 (ref) Furry/feathery Pets NA No 0.94 (0.78−1.13) 0.511 Yes 1 (ref) New furniture/redecoration NA No 0.89 (0.73−1.08) 0.231 Yes 1 (ref) Stressful work or family events
during the first 1 yearNo 0.80 (0.66−0.99) 0.032 1.02 (0.80−1.30) 0.871 Yes 1 (ref) 1 (ref) Often stay up late No 1.00 (0.85−1.17) 0.989 NA Yes 1 (ref) Before surgery FeNO, ppb 1.00 (1.00−1.01) < 0.001 1.00 (0.98−1.02) 0.954 FnNO, ppb 0.99 (0.99−1.00) 0.001 0.99 (0.99−1.01) 0.196 Hb, g/L 1.00 (1.00−1.01) 0.025 0.99 (0.98−1.01) 0.122 IgE, IU/mL 1.00 (0.99−1.01) 0.538 1.00 (1.00−1.01) 0.032 Medical insurance No 1.26 (1.19−1.33) < 0.001 1.23 (1.07−1.42) 0.003 Yes 1 (ref) 1 (ref) Note. CRS, chronic sinusitis; FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; HR, hazard ratio; NA, not applicable. *Adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful work or family events during the first 1 year, FeNO, FnNO, Hb, and medical insurance. S3. Univariable and multivariable Cox regression model of factors associated with all-cause recurrence (All chronic sinusitis patients lost to follow-up are regarded as recovery)
Characteristics All-cause non-recovery Adjusted HR* (95% CI) P-value Socioeconomic status Low 8.77 (7.09−10.87) < 0.001 High 7.19 (5.95−8.70) < 0.001 Middle 1 (ref) Age at operation, years 0.99 (0.98−1.00) 0.111 Sex Males 0.97 (0.83−1.13) 0.722 Females 1 (ref) Nasal polyposis Without 0.88 (0.74−1.05) 0.026 With 1 (ref) Dietary patterns Vegetarian-based 1.52 (0.98−2.51) 0.747 Meat-based 0.64 (0.54−1.54) 0.058 Mixed 1 (ref) Stressful work or family events during the first 1 year No 0.99 (0.80−1.23) 0.919 Yes 1 (ref) Before surgery FeNO, ppb 1.00 (1.00−1.00) 0.527 FnNO, ppb 1.00 (1.00−1.00) 0.224 Hb, g/L 1.00 (1.00−1.01) 0.113 IgE, IU/mL 1.00 (1.00−1.00) 0.538 Medical insurance No 1.23 (1.06−1.56) 0.023 Yes 1 (ref) Note. CRS, chronic sinusitis; FeNO, fractional exhaled nitric oxide; FnNO, fractional nasal nitric oxide; HR, hazard ratio; NA, not applicable. *Adjusted for age at operation, sex, BMI, nasal polyposis, smoking, dietary patterns, stressful work or family events during the first 1 year, FeNO, FnNO, Hb, and medical insurance. S1. Kaplan-Meier analysis of the recovery rate (%) (95 % confidence interval) and Log-rank tests after 24 weeks follow-up
Time (week) Total (n = 1,047) Low (n = 310) Middle (n = 399) High (n = 338) 12 19.1 (18.3−19.9) 3.2 (2.1−4.9) 30.9 (29.2−31.8) 4.7 (3.1−5.9) 24 44.7 (43.7−45.7) 13.5 (12.8−14.2) 90.4 (89.6−91.2) 31.7 (30.7−32.7) -
[1] Sahlstrand-Johnson P, Ohlsson B, von Buchwald C, et al. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology, 2011; 49, 420−8. doi: 10.4193/Rhino11.101 [2] Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol, 2021; 11, 213−739. doi: 10.1002/alr.22741 [3] Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy, 2015; 70, 533−9. doi: 10.1111/all.12577 [4] Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life–an updated review. Chem Senses, 2014; 39, 185−94. doi: 10.1093/chemse/bjt072 [5] Ahmed OG, Rowan NR. Olfactory dysfunction and chronic rhinosinusitis. Immunol Allergy Clin North Am, 2020; 40, 223−32. doi: 10.1016/j.iac.2019.12.013 [6] Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel perioperative sinus endoscopy (POSE) scoring system. Laryngoscope, 2007; 117, 1−28. [7] Al-Qudah M. Refractory chronic rhinosinusitis: a new rhinological disease. Glob J Oto, 2017; 4, 555637. [8] Jiang RS, Lu FJ, Liang KL, et al. Olfactory function in patients with chronic rhinosinusitis before and after functional endoscopic sinus surgery. Am J Rhinol, 2008; 22, 445−8. doi: 10.2500/ajr.2008.22.3195 [9] Soler ZM, Mace J, Smith TL. Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic sinus surgery. Am J Rhinol, 2008; 22, 297−301. doi: 10.2500/ajr.2008.22.3172 [10] Duerson W, Lafer M, Ahmed O, et al. Health care disparities in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis: differences in disease presentation and access to care. Ann Otol Rhinol Laryngol, 2019; 128, 608−13. doi: 10.1177/0003489419834947 [11] Shen SA, Jafari A, Qualliotine JR, et al. Socioeconomic and demographic determinants of postoperative outcome after endoscopic sinus surgery. Laryngoscope, 2020; 130, 297−302. doi: 10.1002/lary.28036 [12] Velasquez N, Gardiner L, Cheng TZ, et al. Relationship between socioeconomic status, exposure to airborne pollutants, and chronic rhinosinusitis disease severity. Int Forum Allergy Rhinol, 2022; 12, 172−80. doi: 10.1002/alr.22884 [13] Beswick DM, Mace JC, Rudmik L, et al. Socioeconomic factors impact quality of life outcomes and olfactory measures in chronic rhinosinusitis. Int Forum Allergy Rhinol, 2019; 9, 231−9. [14] Xiang L, Su ZH, Liu YW, et al. Effect of family socioeconomic status on the prognosis of complex congenital heart disease in children: an observational cohort study from China. Lancet Child Adolesc Health, 2018; 2, 430−9. doi: 10.1016/S2352-4642(18)30100-7 [15] Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis (2018). Chin J Otorhinolaryngol Head Neck Surg, 2019; 54, 81−100. (In Chinese [16] Beswick DM, Mace JC, Soler ZM, et al. Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis. Int Forum Allergy Rhinol, 2019; 9, 1000−9. doi: 10.1002/alr.22374 [17] Odat H, Al-Qudah M. Food elimination in the management of refractory chronic rhinosinusitis: a pilot study. Ear Nose Throat J, 2021; 100, NP424−8. doi: 10.1177/0145561320924150 [18] Alkholaiwi FM, Almutairi RR, Alrajhi DM, et al. Occupational and environmental exposures, the association with chronic sinusitis. Saudi Med J, 2022; 43, 125−31. doi: 10.15537/smj.2022.43.2.20210849 [19] Lind H, Joergensen G, Lange B, et al. Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study. Eur Arch Otorhinolaryngol, 2016; 273, 911−9. doi: 10.1007/s00405-015-3667-9 [20] Kambara R, Minami T, Akazawa H, et al. Lower airway inflammation in eosinophilic chronic rhinosinusitis as determined by exhaled nitric oxide. Int Arch Allergy Immunol, 2017; 173, 225−32. doi: 10.1159/000479387 [21] Ma CJ, Zhang YM, Li Y, et al. Healthcare, insurance, and medical expenditure of the floating population in Beijing, China. Front Public Health, 2020; 8, 375. doi: 10.3389/fpubh.2020.00375 [22] Wang Q, Zhang DL, Hou ZY. Insurance coverage and socioeconomic differences in patient choice between private and public health care providers in China. Soc Sci Med, 2016; 170, 124−32. doi: 10.1016/j.socscimed.2016.10.016 [23] Yang TZ, Rockett IRH, Lv QH, et al. Stress status and related characteristics among urban residents: a six-province capital cities study in China. PLoS One, 2012; 7, e30521. doi: 10.1371/journal.pone.0030521 [24] Xu RH, Wang LL, Zhou LM, et al. Urban-rural differences in financial toxicity and its effect on cancer survivors’ health-related quality of life and emotional status: a latent class analysis. Support Care Cancer, 2022; 30, 4219−29. doi: 10.1007/s00520-021-06762-0 [25] Hao W, Su ZH, Liu BL, et al. Drinking and drinking patterns and health status in the general population of five areas of China. Alcohol Alcohol, 2004; 39, 43−52. doi: 10.1093/alcalc/agh018 [26] Tomljenovic D, Pinter D, Kalogjera L. Perceived stress and severity of chronic rhinosinusitis in allergic and nonallergic patients. Allergy Asthma Proc, 2014; 35, 398−403. doi: 10.2500/aap.2014.35.3774 [27] Lee DJ, Yip J, Lee JM. Nasal nitric oxide as a long-term monitoring and prognostic biomarker of mucosal health in chronic rhinosinusitis. Int Forum Allergy Rhinol, 2020; 10, 971−7. doi: 10.1002/alr.22581 [28] Hellings PW, Fokkens WJ, Orlandi R, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology, 2023; 61, 85−9. -
22431+Supplementary Materials.pdf